MSI2 and pancreatic neoplasm: Interestingly, in pancreatic cancer, a high proportion of circulating tumor cells (CTCs) expressed Msi2 (Msi2+), and were more tumorigenic than Msi2− CTCs, posing a greater risk for tumor dissemination [33].